Nuclear accumulation of p53 correlates significantly with clinical features and inversely with the expression of the cyclin-dependent kinase inhibitor p21(WAF1/CIP1) in pancreatic cancer.

Recent studies have suggested a p53-independent expression of p21(WAF1/CIP1). We investigated the correlation between p53 overexpression and the expression of p21(WAF1/CIP1) in 57 patients with pancreatic adenocarcinoma. By means of reverse transcription and polymerase chain reaction (RT-PCR), we examined the mRNA levels of WAF1/CIP1 and compared them with the p53 status in 20 patients and in a further six pancreatic tumour cell lines. In pancreatic cancer tissues, immunohistological evaluation revealed a significant correlation between active p53 and p21(WAF1/CIP1) (P < 0.005) as well as WAF1/CIP1 mRNA expression (P < 0.005). This coherence was also evident in human pancreatic carcinoma cell lines. The analysis of p53 and p21(WAF1/CIP1) expression in relation to clinicopathological features revealed a significant correlation between p53 overexpression and tumour stage, tumour size, grading and lymph node metastases, whereas p21(WAF1/CIP1) expression correlated only with tumour size. We conclude that the expression of p21(WAF1/CIP1) normally depends on active p53, but that there may also exist p53-independent pathways of induction that reduce the correlation of p21(WAF1/CIP1) to clinicopathological features.

• Publication year

  1997

• Venue

  British Journal of Cancer

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1038/bjc.1997.382PMID 9252195PMCID 2224055
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The role of anti-p53-autoantibodies in pancreatic disorders

  1996cited by this paper
• Prognostic significance of abnormal p53 accumulation in primary, resected non-small-cell lung cancers.

  1996cited by this paper
• Effects of p53 mutants on wild-type p53-mediated transactivation are cell type dependent.

  1995cited by this paper
• p53-independent expression of the cyclin-dependent kinase inhibitor p21 in pancreatic carcinoma.

  1995cited by this paper
• p53 protein accumulation in European hepatocellular carcinoma is not always dependent on p53 gene mutation.

  1995cited by this paper
• Irradiation Induces WAF1 Expression through a p53-independent Pathway in KG-1 Cells (*)

  1995cited by this paper
• Assessment of sensitivity and specificity of immunohistochemical staining of p53 in lung and head and neck cancers.

  1995cited by this paper
• Posttranscriptional stabilization underlies p53-independent induction of p21WAF1/CIP1/SDI1 in differentiating human leukemic cells.

  1995cited by this paper
• p53-independent expression of p21Cip1 in muscle and other terminally differentiating cells

  1995cited by this paper
• Apoptosis in cancer therapy: crossing the threshold.

  1994cited by this paper
• Absence of WAF1 mutations in a variety of human malignancies.

  1994cited by this paper
• Induction of WAF1/CIP1 by a p53-independent pathway.

  1994cited by this paper
• WAF1/CIP1 is induced in p53-mediated G1 arrest and apoptosis.

  1994cited by this paper
• Analysis of the most representative tumour‐derived p53 mutants reveals that changes in protein conformation are not correlated with loss of transactivation or inhibition of cell proliferation.

  1994cited by this paper
• p53 mutations in pancreatic carcinoma and evidence of common involvement of homocopolymer tracts in DNA microdeletions.

  1994cited by this paper
• K-ras and p53 gene mutations in pancreatic cancer: ductal and nonductal tumors progress through different genetic lesions.

  1994cited by this paper
• p53-dependent inhibition of cyclin-dependent kinase activities in human fibroblasts during radiation-induced G1 arrest.

  1994cited by this paper
• WAF1, a potential mediator of p53 tumor suppression.

  1993cited by this paper
• The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases.

  1993cited by this paper
• Pancreatic adenocarcinomas frequently show p53 gene mutations.

  1993cited by this paper
• Immunohistochemical demonstration of the p53 tumour suppressor gene product in cancer of the pancreas and chronic pancreatitis

  1993cited by this paper
• p53 mutations are common in pancreatic cancer and are absent in chronic pancreatitis.

  1993cited by this paper
• Quantitation of beta-actin-specific mRNA transcripts using xeno-competitive PCR.

  1993cited by this paper
• p21 is a universal inhibitor of cyclin kinases

  1993cited by this paper
• p53 function and dysfunction.

  1992cited by this paper
• P53 in tumour pathology: Can we trust immunocytochemistry?

  1992cited by this paper
• A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in ataxia-telangiectasia.

  1992cited by this paper
• Constant denaturant gel electrophoresis as a rapid screening technique for p53 mutations.

  1991cited by this paper
• p53 mutations in human cancers.

  1991cited by this paper
• p53 immunostaining as a marker of malignant disease in diagnostic cytopathology.

  1991cited by this paper
• Identification of p53 as a sequence-specific DNA-binding protein

  1991cited by this paper
• Abnormalities of the p53 tumour suppressor gene in human pancreatic cancer.

  1991cited by this paper
• Activating mutations for transformation by p53 produce a gene product that forms an hsc70-p53 complex with an altered half-life

  1988cited by this paper

• Low-Grade Endometrial Cancer with Abnormal p53 Expression as a Separate Clinical Entity: Insights from RNA Sequencing and Immunohistochemistry

  2025cites this paper
• High p53 Protein Level Is a Negative Prognostic Marker for Pancreatic Adenocarcinoma

  2024cites this paper
• Systematic review and meta-analysis of relationship between p53 protein expression and lymph node metastasis, vascular invasion, and perineural invasion in pancreatic cancer

  2024cites this paper
• p21 Protein Outperforms Clinico-pathological Criteria in Predicting Liver Metastases in Pancreatic Endocrine Tumors

  2023cites this paper
• Cdc7 is a potent anti-cancer target in pancreatic cancer due to abrogation of the DNA origin activation checkpoint

  2016cites this paper
• P53 overexpression and Ki67-index are associated with outcome in ductal pancreatic adenocarcinoma with adjuvant gemcitabine treatment.

  2016cites this paper
• The Role of PI3K Signaling Pathway in Intestinal Tumorigenesis

  2015cites this paper
• Chapter 1 Pancreatic cancer , an introductory overview , and outline of the thesis

  2013cites this paper
• Genetic Markers of Malignant Transformation in Intraductal Papillary Mucinous Neoplasm of the Pancreas: A Meta-Analysis

  2012cites this paper
• Systematic review of immunohistochemical biomarkers to identify prognostic subgroups of patients with pancreatic cancer

  2011cites this paper
• Tumor growth suppression by adenovirus-mediated introduction of a cell-growth-suppressing gene tob in a pancreatic cancer model.

  2009cites this paper
• Pancreatic Carcinogenesis

  2008cites this paper
• The molecular basis of pancreatic cancer

  2007cites this paper
• Comparative evaluation of p53 mutation in pancreatic adenocarcinoma and chronic pancreatitis.

  2006cites this paper
• The HAUSP gene plays an important role in non‐small cell lung carcinogenesis through p53‐dependent pathways

  2006cites this paper
• Chemoprevention of Pancreatic Cancer: A Review of the Molecular Pathways Involved, and Evidence for the Potential for Chemoprevention

  2006cites this paper
• The immunohistochemical expression of p21WAF1/Cip1 and Proliferating cell nuclear antigen in laryngeal squamous cell carcinomas.

  2006cites this paper
• Amplification and overexpression of HER-2/neu in invasive ductal carcinomas of the pancreas and pancreatic intraepithelial neoplasms and the relationship to the expression of p21(WAF1/CIP1).

  2004cites this paper
• Relationship between K-ras mutation and the expression of p21WAF1/CIP1 and p53 in chronic pancreatitis and pancreatic adenocarcinoma.

  2003cites this paper
• Minichromosome maintenance 2 expression is correlated with mode of invasion and prognosis in oral squamous cell carcinomas.

  2003cites this paper
• Reduced ING 1 b Gene Expression Plays an Important Role in Carcinogenesis of Non-Small Cell Lung Cancer Patients

  2003cites this paper
• Reduced ING1b gene expression plays an important role in carcinogenesis of non-small cell lung cancer patients.

  2003cites this paper
• Acrylonitrile exposure: the effect on p53 and p21(WAF1) protein levels in the blood plasma of occupationally exposed workers and in vitro in human diploid lung fibroblasts.

  2002cites this paper
• Comparative study of non‐functional islet cell tumors and pancreatic solid and papillary neoplasms: Biological behavior and immunohistochemistry

  2002cites this paper
• The importance of drug scheduling and recovery phases in determining drug activity. Improving etoposide efficacy in BCR-ABL-positive CML cells.

  2002cites this paper
• Expression of heparin-binding epidermal growth factor-like growth factor in pancreatic adenocarcinoma

  2001cites this paper
• Transcription factors and other dysregulated proteins in melanoma prognosis

  2001cites this paper
• Correlation between TGF-beta1 and p21 (WAF1/CIP1) expression and prognosis in resectable invasive ductal carcinoma of the pancreas.

  2001cites this paper
• Expression of p57/Kip2 Protein in Pancreatic Adenocarcinoma

  2001cites this paper
• PROGNOSTIC VALUE OF EXPRESSION OF CYCLIN DEPENDENT KINASE INHIBITOR p21 AND LUNG RESISTANCE PROTEIN AS PREDICTING FACTORS IN BREAST CANCER

  2001cites this paper
• p53 accumulation confers prognostic information in resectable adenocarcinomas with ductal but not with intestinal differentiation in the pancreatic head.

  2000cites this paper
• Cyclin-dependent kinase inhibitory protein expression in human choroidal melanoma tumors.

  2000cites this paper
• Protein expression of p53, p21 (WAF1/CIP1), bcl-2, Bax, cyclin D1 and pRb in human colon carcinomas

  2000cites this paper
• Evaluation of PCNA, p53, K-ras and LOH in endocrine pancreas tumors.

  2000cites this paper
• Ki-ras point mutation and p53 expression in human pancreatic cancer: a comparative study among Chinese, Japanese, and Western patients.

  2000cites this paper
• Cyclin D1 expression is predictive of occult metastases in head and neck cancer patients with clinically negative cervical lymph nodes

  2000cites this paper
• Increased angiogenin expression in gastric cancer correlated with cancer progression

  2000cites this paper
• Diverse effects of 9-hydroxyellipticine on the chemosensitivity of human pancreatic cancer cells harboring p53 mutations.

  2000cites this paper
• Screening for early pancreatic ductal adenocarcinoma in hereditary pancreatitis.

  2000cites this paper
• p21WAF1 expression is associated with improved survival after adjuvant chemoradiation for pancreatic cancer.

  2000cites this paper
• Induction of p21WAF1/CIP1and Inhibition of Cdk2 Mediated by the Tumor Suppressor p16INK4a

  1999cites this paper
• Induction of p21 WAF1/CIP1 and Inhibition of Cdk2 Mediated by the Tumor Suppressor p16 INK4a

  1999cites this paper
• Lack of independent prognostic significance of p21 and p27 expression in advanced ovarian cancer: an immunohistochemical study.

  1999cites this paper
• Increased angiogenin expression in obstructive chronic pancreatitis surrounding pancreatic cancer but not in pure chronic pancreatitis.

  1999cites this paper
• Downregulation of p21/WAF1 is related to advanced and dedifferentiated laryngeal squamous cell carcinoma.

  1999cites this paper
• Proliferation- and apoptosis-associated factors in advanced prostatic carcinomas before and after androgen deprivation therapy: prognostic significance of p21/WAF1/CIP1 expression

  1999cites this paper
• p21/WAF1 expression as related to p53, cell proliferation and prognosis in epithelial ovarian cancer

  1999cites this paper
• Induction of cell‐cycle arrest and apoptosis by a novel retinobenzoic‐acid derivative, TAC‐101, in human pancreatic‐cancer cells

  1999cites this paper
• Molecular Aspects of Pancreatic Cancer and Future Perspectives

  1999cites this paper
• Basal expression and cytokine induction of intercellular adhesion molecule-1 in human pancreatic cancer cell lines.

  1999cites this paper
• p53 in Relation to Therapeutic Outcome of Locoregional Chemotherapy in Pancreatic Cancer

  1999cites this paper
• Increased serum angiogenin concentration in colorectal cancer is correlated with cancer progression.

  1999cites this paper
• Growth Factors and Transcription Factors in Pancreatic Cancer

  1999cites this paper
• p21WAF1/CIP1expression in stage I cutaneous malignant melanoma: its relationship with p53, cell proliferation and survival

  1999cites this paper
• Comparative Study of p53 Expression in Primary Invasive Ductal Carcinoma of the Pancreas Between Chinese and Japanese

  1998cites this paper
• Prognostische Wertigkeit molekularbiologischer und immunologischer Parameter beim humanen Pankreaskarzinom

  1998cites this paper
• Expression and alteration of p53 and p21(waf1/cip1) influence the sensitivity of chemoradiation therapy for esophageal cancer.

  1998cites this paper
• Prognostic significance of molecular alterations in human pancreatic carcinoma – an immunohistological study

  1998cites this paper
• Overexpression of cyclin D1 in human pancreatic carcinoma is associated with poor prognosis.

  1997cites this paper